Michael J. Cieslewicz
Corporate Officer/Principal chez Vigeo Therapeutics, Inc.
Postes actifs de Michael J. Cieslewicz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Historique de carrière de Michael J. Cieslewicz
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Michael J. Cieslewicz
- Expérience